As a result, the Ki-67 index (Supplement Figure S1, left), a widely used prognostic factor in breast cancer and a marker of proliferation, as well as the relative proliferation rate of the tumor cells in grid-based cell counts (Supplement Figure S1, right panels) decreased in a dose-dependent manner by all tested chemotherapeutics. Here, MKI67 is linked to breast carcinoma.